97 related articles for article (PubMed ID: 23554035)
1. Effects of tetra-arsenic tetra-sulfide on BXSB lupus-prone mice: a pilot study.
Zhao Y; Wen G; Qiao Z; Xu H; Sun Q; Huang H; Shan S; Mu Z; Zhang J
Lupus; 2013 Apr; 22(5):469-76. PubMed ID: 23554035
[TBL] [Abstract][Full Text] [Related]
2. Tetra-arsenic tetra-sulfide ameliorates lupus syndromes by inhibiting IL-17 producing double negative T cells.
Zhao Y; Mu Z; Cai L; Liu X; Jia J; Zhang J
Dermatol Ther; 2019 Jul; 32(4):e12849. PubMed ID: 30707471
[TBL] [Abstract][Full Text] [Related]
3. FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice.
Ando S; Amano H; Amano E; Minowa K; Watanabe T; Nakano S; Nakiri Y; Morimoto S; Tokano Y; Lin Q; Hou R; Ohtsuji M; Tsurui H; Hirose S; Takasaki Y
Biochem Biophys Res Commun; 2010 Apr; 394(3):804-10. PubMed ID: 20233577
[TBL] [Abstract][Full Text] [Related]
4. [Effects of arsenic trioxide on the autoimmunity and survival time in BXSB lupus mice].
Xia XR; Lin SX; Zhou Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Feb; 27(2):138-41. PubMed ID: 17345664
[TBL] [Abstract][Full Text] [Related]
5. Tetra-arsenic tetra-sulfide enhances NK-92MI mediated cellular immunotherapy in all-trans retinoic acid-resistant acute promyelocytic leukemia.
Liu Y; Jia Y; Liu Y; Chen X; Zhang M
Invest New Drugs; 2022 Dec; 40(6):1231-1243. PubMed ID: 36287298
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-CD134L mAb and CTLA4Ig on ConA-induced proliferation, Th cytokine secretion, and anti-dsDNA antibody production in spleen cells from lupus-prone BXSB mice.
Zhou YB; Ye RG; Li YJ; Xie CM; Wu YH
Autoimmunity; 2008 Aug; 41(5):395-404. PubMed ID: 18568645
[TBL] [Abstract][Full Text] [Related]
7. [Effect of the tetra-arsenic tetra-sulfide (As4S4) on the corrected QT interval in the treatment of acute promyelocytic leukemia].
Shen JC; Liu KY; Jiang B; Lu XJ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):359-61. PubMed ID: 15308017
[TBL] [Abstract][Full Text] [Related]
8. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo.
Zhang L; Tian W; Kim S; Ding W; Tong Y; Chen S
Drug Des Devel Ther; 2015; 9():79-92. PubMed ID: 25565771
[TBL] [Abstract][Full Text] [Related]
9. Arsenic sulfide as a potential anti‑cancer drug.
Ding W; Zhang L; Kim S; Tian W; Tong Y; Liu J; Ma Y; Chen S
Mol Med Rep; 2015 Feb; 11(2):968-74. PubMed ID: 25371265
[TBL] [Abstract][Full Text] [Related]
10. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH
Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of tetra-arsenic tetra-sulfide in inducing apoptosis of acute promyelocytic leukemia cells].
Teng ZP; Zhang P; Zhu HH; Hao HY; Qin XY; Hao L; Xu H; Lu DP
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):236-8. PubMed ID: 16778962
[TBL] [Abstract][Full Text] [Related]
12. Effects of Arsenic Trioxide on INF-gamma Gene Expression in MRL/lpr Mice and Human Lupus.
Hu H; Chen E; Li Y; Zhu X; Zhang T; Zhu X
Biol Trace Elem Res; 2018 Aug; 184(2):391-397. PubMed ID: 29159556
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group box 1 inhibition alleviates lupus-like disease in BXSB mice.
Zhang C; Li C; Jia S; Yao P; Yang Q; Zhang Y
Scand J Immunol; 2014 May; 79(5):333-7. PubMed ID: 24612327
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
15. The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice.
Izui S; Higaki M; Morrow D; Merino R
Eur J Immunol; 1988 Jun; 18(6):911-5. PubMed ID: 3260184
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis of murine lupus T cells induced by the selective cyclooxygenase-2 inhibitor celecoxib: molecular mechanisms and therapeutic potential.
Yang P; Zhang Y; Ping L; Gao XM
Int Immunopharmacol; 2007 Nov; 7(11):1414-21. PubMed ID: 17761345
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
18. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
19. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice.
Wofsy D
J Immunol; 1986 Jun; 136(12):4554-60. PubMed ID: 3086436
[TBL] [Abstract][Full Text] [Related]
20. Suppression of systemic lupus erythematosus disease in mice by oral administration of kidney extract.
Ofosu-Appiah W; Sfeir G; Viti D; Burashnikova E
J Autoimmun; 1999 Dec; 13(4):405-14. PubMed ID: 10585756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
